Alzheimer's disease trials recruiting in Oregon

All Alzheimer's disease trials nationally

Cities in Oregon

Recruiting trials in Oregon

• A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
  NCT07170150 · Phase: Phase 3 · Ages: 50 Years to 90 Years · Sex: All (male and female) · Oregon: Portland
• A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
  NCT07094516 · Phase: Phase 2 · Ages: 50 Years to 85 Years · Sex: All (male and female) · Oregon: Portland
• A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
  NCT07589595 · Phase: Phase 2 · Ages: 55 Years to 85 Years · Sex: All (male and female) · Oregon: Portland
• A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
  NCT06887192 · Phase: Phase 2 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Oregon: Tigard
• A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
  NCT06976216 · Phase: Phase 3 · Ages: 60 Years to 85 Years · Sex: All (male and female) · Oregon: Portland
• Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
  NCT06563895 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Oregon: Portland
• OCT Angiography and NRAI in Dementia
  NCT03761381 · Phase: Not specified · Ages: 55 Years and older · Sex: All (male and female) · Oregon: Portland
• Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
  NCT07284472 · Phase: Phase 2, Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Oregon: Portland
• Safety and Target Engagement of Centella Asiatica in Cognitive Impairment
  NCT05591027 · Phase: Phase 1 · Ages: 60 Years to 85 Years · Sex: All (male and female) · Oregon: Portland
• Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
  NCT07177352 · Phase: Phase 3 · Ages: 50 Years to 90 Years · Sex: All (male and female) · Oregon: Portland
• Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
  NCT06847321 · Phase: Phase 2 · Ages: 55 Years to 80 Years · Sex: All (male and female) · Oregon: Portland
• Trial-Ready Cohort-Down Syndrome (TRC-DS)
  NCT04165109 · Phase: Not specified · Ages: 25 Years to 55 Years · Sex: All (male and female) · Oregon: Portland